Kevin Kinsella

Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA.

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL.

InCode BioPharmaceutics, Inc. developed and manufactured biotechnology products.. The company was founded in 2006 and was headquartered in La Jolla, CA.

ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. The firm operates as a ophthalmic biopharmaceutical company. Its products include Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in April 2010 and is headquartered in La Jolla, CA.

Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA.

Juliet Marine Systems, Inc. develops solutions for naval and commercial applications. It develops manned, unmanned, surface and subsurface maritime transport technology systems for commercial, surface warfare, submarine warfare and special operations communities. Its products are used for applications, such as force protection, special operations support, anti-submarine warfare, mine warfare, intelligence, surveillance and reconnaissance, high speed maritime ferry and taxi, offshore oil rig supply vessel and pleasure craft. The company was founded by Gregory E. Sancoff in 2004 and is headquartered in Portsmouth, NH.

Spectragraphics Corp. engaged in the manufacturing of electronic products and computers. The company was founded by Kevin J. Kinsella on September 14, 1981 and was headquartered in San Diego, CA.

X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents

Akesis Pharmaceuticals, Inc. develops and commercializes advanced therapeutics for metabolic disorder diseases such as diabetes, obesity and dyslipidemia. Akesis Pharmaceuticals was founded in 1990 and is headquartered in La Jolla, CA.

Ansata Therapeutics, Inc. develops biopharmaceutical products. It develops and commercializes topical drugs for dermatologic indications. The company was founded by Brian A. Pollok in 2002 and is headquartered in La Jolla, CA.

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

Solar Turbines, Inc. manufactures industrial gas turbines. Its products are used for developing oil, natural gas and power generation projects. The company was founded on November 13, 1927 and is headquartered in San Diego, CA.

Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.

Sirion Therapeutics, Inc. provides biopharmaceutical products and services. It manufactures, develops and commercialize ophthalmic products for eye diseases. The company was founded by Barry Butler, Susan Benton, Philippe Boulangeat and Roger Vogel in November 2005 and is headquartered in Tampa, FL.

Part of Bausch Health Cos., Inc., Sytera, Inc. is a biopharmaceutical company that provides biopharmaceutical services and products. The private company is based in La Jolla, CA. The company was founded by Jay B. Lichter, Kenneth J. Widder, Nathan L. Mata. Sytera was acquired by Sirion Therapeutics, Inc. on August 16, 2006 for $250 million.

The Broadway League offers entertainment services. It provides entertainment services including the production of theatrical plays, musicals and other stage performances. The company was founded in 1930 and is headquartered in New York, NY.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA.

Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA.

Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA.